Provided by Tiger Trade Technology Pte. Ltd.

BOAN BIOTECH

3.610
-0.120-3.22%
Volume:6.10M
Turnover:22.07M
Market Cap:2.24B
PE:249.23
High:3.770
Open:3.770
Low:3.585
Close:3.730
52wk High:15.960
52wk Low:3.585
Shares:620.00M
HK Float Shares:620.00M
Volume Ratio:1.21
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.014
ROE:-4.11%
ROA:-1.28%
PB:0.72
PE(LYR):249.22
PS:3.07

Loading ...

Boan Biotech Maintains 622.33 Million Issued Shares and Meets Public‐Float Requirement in April 2026

Bulletin Express
·
May 07

BOAN BIOTECH's Stock Plummets Nearly 70% in Eight Months, Faces Critical Test to Maintain Stock Connect Eligibility

Stock News
·
May 01

博安生物营收破7.848亿元净利同比下滑 资本与研发投入助力长期增长

Bulletin Express
·
Apr 29

Boan Biotech’s 2025 ESG Report: Quad-ISO Certification, 50 Patents Granted and 13,468 tCO₂e Emissions

Bulletin Express
·
Apr 29

Shandong Boan Biotech publishes 2025 annual report

Reuters
·
Apr 29

Boan Biotech Announces Proposed Adoption of Restricted Share Unit Incentive Scheme for H Shares

Bulletin Express
·
Apr 28

BOAN BIOTECH Proposes Restricted Share Unit Incentive Scheme

Stock News
·
Apr 28

Shandong Boan Bio proposes H-share restricted share unit incentive scheme

Reuters
·
Apr 28

BOAN BIOTECH Secures CDE Approval to Launch Phase II Trial of BA1106 + BA1104 for Driver-Gene-Negative NSCLC

Bulletin Express
·
Apr 26

BOAN BIOTECH Receives CDE Acceptance for Phase II Trial Application of BA1106 Combined with BA1104 in Non-Small Cell Lung Cancer

Stock News
·
Apr 26

Shandong Boan says China CDE accepts Phase II trial application for BA1106-BA1104 combo in NSCLC

Reuters
·
Apr 26

Boan Biotech’s March Filing Shows Stable Share Base and Sufficient Public Float

Bulletin Express
·
Apr 08

BRIEF-Shandong Boan Biotechnology Says Dou Changlin Resigned As Executive Director

Reuters
·
Apr 01

BOAN BIOTECH Announces Executive Reshuffle and Strategic Committee Changes

Stock News
·
Mar 31

Boan Biotech Announces Retirement of Executive Director Dr. Dou and Strategy Committee Realignment Effective 31 March 2026

Bulletin Express
·
Mar 31

Shandong Boan Biotechnology - Dou Changlin Resigned as Executive Director

THOMSON REUTERS
·
Mar 31

Stock Track | BOAN BIOTECH Plummets 5.15% Intraday After Reporting 90.24% Profit Drop in FY2025 Results

Stock Track
·
Mar 31

BOAN BIOTECH Reports Annual Results: Profit Attributable to Owners Narrows Significantly

Stock News
·
Mar 31

Boan Biotech FY25 profit drops 90.24% to RMB 7.1 million; revenue rises 8.1% to RMB 780 million

Reuters
·
Mar 30

Shandong Boan Biotechnology FY Revenue RMB 784.8 Million

THOMSON REUTERS
·
Mar 30